Guinea vs Niger: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Guinea
2.8%
in 2024
Niger
3.2%
in 2024
Guinea rank
6th
Niger rank
3rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Guinea
- Niger
How they compare
Niger currently reports 3.2% against 2.8% in Guinea, a difference of 0.4%.
That makes Niger's figure about 1.1 times Guinea's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Guinea ahead.
Guinea ranks 6th and Niger ranks 3rd of 215 countries.
Across the 2 decades both report, Guinea averaged higher in 1 and Niger in 1.
Head to head by decade
| Decade | Guinea | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 2.6% | 0.1% | Guinea |
| 2020s | 2.7% | 3.4% | 0.7% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Guinea or Niger?
- Niger, at 3.2% against 2.8% in Guinea as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Guinea and Niger?
- 0.4%, with Niger ahead.
- How many years of comparable data are there for Guinea and Niger?
- 10 years are reported by both, from 2015 to 2024.
- How do Guinea and Niger rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Guinea ranks 6th and Niger ranks 3rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.